Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
7.04
+0.06 (0.86%)
At close: Dec 11, 2025, 4:00 PM EST
7.01
-0.03 (-0.43%)
After-hours: Dec 11, 2025, 5:15 PM EST
Neogen Revenue
Neogen had revenue of $209.19M in the quarter ending August 31, 2025, a decrease of -3.58%. This brings the company's revenue in the last twelve months to $886.89M, down -2.77% year-over-year. In the fiscal year ending May 31, 2025, Neogen had annual revenue of $894.66M, down -3.20%.
Revenue (ttm)
$886.89M
Revenue Growth
-2.77%
P/S Ratio
1.71
Revenue / Employee
$298,213
Employees
2,974
Market Cap
1.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 894.66M | -29.56M | -3.20% |
| May 31, 2024 | 924.22M | 101.78M | 12.37% |
| May 31, 2023 | 822.45M | 295.29M | 56.01% |
| May 31, 2022 | 527.16M | 58.70M | 12.53% |
| May 31, 2021 | 468.46M | 50.29M | 12.03% |
| May 31, 2020 | 418.17M | 3.98M | 0.96% |
| May 31, 2019 | 414.19M | 16.26M | 4.09% |
| May 31, 2018 | 397.93M | 39.65M | 11.07% |
| May 31, 2017 | 358.28M | 37.00M | 11.52% |
| May 31, 2016 | 321.28M | 38.20M | 13.50% |
| May 31, 2015 | 283.07M | 35.67M | 14.42% |
| May 31, 2014 | 247.41M | 39.88M | 19.22% |
| May 31, 2013 | 207.53M | 23.48M | 12.76% |
| May 31, 2012 | 184.05M | 11.36M | 6.58% |
| May 31, 2011 | 172.68M | 32.17M | 22.90% |
| May 31, 2010 | 140.51M | 21.79M | 18.35% |
| May 31, 2009 | 118.72M | 16.30M | 15.92% |
| May 31, 2008 | 102.42M | 16.28M | 18.90% |
| May 31, 2007 | 86.14M | 13.71M | 18.92% |
| May 31, 2006 | 72.43M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NEOG News
- 6 weeks ago - Neogen® Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer - Business Wire
- 2 months ago - Animal Tester Neogen Sticks To Annual Forecast Despite Tariffs - Benzinga
- 2 months ago - Neogen Corporation (NEOG) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Neogen Announces First-Quarter 2026 Results - Business Wire
- 2 months ago - Top Wall Street Forecasters Revamp Neogen Expectations Ahead Of Q1 Earnings - Benzinga
- 2 months ago - Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education - Business Wire
- 3 months ago - Neogen Announces First-Quarter Earnings Release Date - Business Wire
- 3 months ago - Neogen® Announces CFO Transition Plan - Business Wire